A phase II trial of conventional radiation therapy (XRT) plus high dose tamoxifen (TAM) for the treatment of supratentorial glioblastoma multiforme (GBM): RTOG protocol BR-0021

被引：0
|
作者：
Robins, H [1 ]
Won, N [1 ]
Seiferheld, W [1 ]
Schultz, C [1 ]
Choucair, A [1 ]
Brachman, D [1 ]
Demas, W [1 ]
Mehra, MP [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [31] Phase II trial of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme
    Lai, A.
    Nghiemphu, P.
    Green, R.
    Spier, L.
    Peak, S.
    Phuphanich, S.
    Fehrenbacher, L.
    Kolevska, T.
    Polikoff, J.
    Cloughesy, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] UPDATED RESULTS OF PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Lai, Albert
    Nghiemphu, Phioanh
    Green, Richard M.
    Spier, Liz
    Peak, Scott
    Phuphanich, Surasak
    Fehrenbacher, Lou
    Kolevska, Tatjana
    Polikoff, Jonathan A.
    Cloughesy, Timothy F.
    NEURO-ONCOLOGY, 2009, 11 (05) : 632 - 632
  • [33] Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119)
    Berk, Lawrence
    Berkey, Brian
    Rich, Tyvin
    Hrushesky, William
    Blask, David
    Gallagher, Michael
    Kudrimoti, Mahesh
    McGarry, Ronald C.
    Suh, John
    Mehta, Minesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 852 - 857
  • [34] Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of north central cancer treatment group protocol N0177
    Krishnan, Sunil
    Brown, Paul D.
    Ballman, Karla V.
    Fiveash, John B.
    Uhm, Joon H.
    Giannini, Caterina
    Jaeckle, Kurt A.
    Geoffroy, Francois J.
    Nabors, L. Burt
    Buckner, Jan C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1192 - 1199
  • [35] LONG-TERM FOLLOW-UP OF A PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ranjan, Tulika
    Desjardins, Annick
    Peters, Katherine B.
    Alderson, Lloyd
    Kirkpatrick, John
    Herndon, James, II
    Bailey, Leighann
    Sampson, John
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James
    NEURO-ONCOLOGY, 2012, 14 : 81 - 82
  • [36] A PHASE II STUDY OF MULTIMODAL THERAPY EMPLOYING SURGERY, CARMUSTINE (BCNU) WAFER, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Rezazadeh, Arash
    LaRocca, Renato V.
    Vitaz, Todd W.
    Villanueva, Wayne G.
    Hodes, Jonathan
    Haysley, Leslie
    NEURO-ONCOLOGY, 2011, 13 : 90 - 90
  • [37] PHASE I/II TRIAL OF TEMOZOLOMIDE (TMZ), MOTEXAFIN GADOLINIUM (MGD), AND 60-GY FRACTIONATED RADIATION (RT) FOR NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA: RESULTS OF RTOG 0513 PHASE I DOSE ESCALATION TOXICITY ANALYSIS
    Brachman, David
    Wang, Meihua
    Ashby, Lynn
    Stea, Baldassarre
    Thomas, Theresa
    Mehta, Minesh
    NEURO-ONCOLOGY, 2008, 10 (05) : 889 - 889
  • [38] Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20
    Lieberman, F. S.
    Berkey, B.
    Tsien, C.
    Curran, W.
    Werner-Wasik, M.
    Smith, R.
    Grossheirn, L.
    Hugh, E.
    Mehta, M.
    NEURO-ONCOLOGY, 2006, 8 (04) : 445 - 445
  • [39] Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20.
    Lieberman, F. S.
    Tsien, C.
    Berkey, B.
    Curran, W.
    Werner-Wasik, M.
    Smith, R.
    Grossheim, L.
    Hug, E.
    Mehta, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 60S - 60S
  • [40] A PILOT PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (hypo-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ney, Douglas
    Carlson, Julie
    Damek, Denise
    Blatchford, Patrick
    Gaspar, Laurie
    Kavanagh, Brian
    Waziri, Allen
    Lillehei, Kevin
    Reddy, Krishna
    Chen, Changhu
    NEURO-ONCOLOGY, 2013, 15 : 80 - 81
12345